LXEO stock news
This page provides real-time market news, earnings updates, and company announcements related to Lexeo Therapeutics, Inc. (LXEO).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-06-27 06:04 EST
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
Finviz2026-03-03 12:33:14
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Finviz2026-03-30 20:09:51
Lexeo Therapeutics announced that the launch of its Sunrise-Fa 2 project is progressing steadily as planned, with the goal of completion in the second quarter of 2026.
老虎证券2026-06-15 11:10:05
LXEO stock chart
LXEO stock detailsLXEO stock price change
On the last trading day, LXEO stock closed at 4.73 USD, with a price change of 0.64% for the day.
Trade spot stocks (24/7)Trade stock perps (up to 100x leverage)About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
To provide deeper liquidity, a more transparent trading experience, and greater capital efficiency, Bitget officially launched its all-new spot stock product, Bitget Stocks 2.0, on June 2, 2026.
The new product is independently issued by licensed RWA protocol Reality, with Bitget providing strategic support and asset security safeguards. This marks a major upgrade to the stock trading experience.
Bitget is moving stock trading beyond the limits of traditional trading models by fully integrating stock assets into its margin and yield ecosystem.
Learn more